BIOSYNTHESIS OF CANNABINOIDS FROM CANNABIGEROLIC ACID USING NOVEL CANNABINOID SYNTHASES

Abstract

A method for producing a cannabinoid by contacting cannabigerolic acid with a cannabinoid synthase orthologue. The cannabinoid synthase orthologue is from an organism other than Cannabis sativa. Also disclosed is a recombinant cell of Saccharomyces cerevisiae or Pichia pastoris that includes in its genome a nucleic acid encoding the above cannabinoid synthase orthologue. The cannabinoid synthase orthologue is expressed in the recombinant cell in an active form.

Description

BACKGROUND

The cannabinoid biosynthetic pathway has been the subject of intense investigation. Cloning and expression of the various enzymes in the cannabinoid biosynthetic pathway has been accomplished by several research groups. For example, the structure and function of Δ¹-tetrahydrocannabinolic acid synthase, i.e., a cannabinoid synthase, has been elucidated. See Shoyama et al., J. Mol. Biol. 2012, 423(1):96-105.

The biosynthesis of two cannabinoids, cannabidiolic acid and Δ⁹-tetrahydrocannabinolic acid, has been accomplished by expressing cannabinoid biosynthetic pathway enzymes from Cannabis sativa and other organisms heterologously in Saccharomyces cerevisiae. See, e.g., Luo et al., Nature 2019, 567(7746):123-126 and Zirpel et al., J. Biotechnol. 2017, 259:204-212. Studies such as these have established that it is possible to build the cannabinoid biosynthetic pathway in a heterologous system.

Additional enzymes and methods are needed for synthesizing cannabinoids with specificity and high yield.

SUMMARY

A method is disclosed for producing a cannabinoid. The method includes the steps of contacting cannabigerolic acid with a cannabinoid synthase orthologue. The cannabinoid synthase orthologue is from an organism other than Cannabis sativa, e.g., Citrus sinensis, Cucumis melo, Capsicum annuum, Brassica napus, Nicotiana attenuata, Nicotiana tabacum, Noccaea caerulescens (Thlaspi caerulescens), Gossypium hirsutum (Gossypium mexicanum), Oryza sativa subsp. indica, Oryza sativa subsp. japonica, Arabidopsis lyrata subsp. lyrata, Paenibacillus sp. Aloe-11, Streptomyces ipomoeae 91-03, Brassica rapa subsp. pekinensis, Prunus persica, Bacillus subtilis 168, Arabidopsis thaliana, Papaver somniferum and Phytophthora parasitica P1569.

Also provided are recombinant cells of Saccharomyces cerevisiae and Pichia pastoris that each include in their genomes a nucleic acid encoding a cannabinoid synthase orthologue, wherein the cannabinoid synthase orthologue is from any of the organisms listed in the preceding paragraph, and the cannabinoid synthase orthologue is expressed in the recombinant cells in an active form.

The details of one or more embodiments are set forth in the description and the examples below. Other features, objects, and advantages will be apparent from the detailed description, from the drawings, and also from the appended claims.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention description below refers to the accompanying drawings, of which:

FIG. 1 shows cannabinoid products that can be formed from cannabigerolic acid (“CBGA”) as substrate. The molecular formula and formula weight of cannabielsoic acid (“CBEA”) is C₂₂H₃₀O₅ and 374.5, respectively. The respective molecular formula and formula weight of cannabielsoin (decarboxylated CBEA) is C₂₁H₃₀O₃ and 330.5. The molecular formula and formula weight of all other compounds shown are C₂₂H₃₀O₄ and 358.5, respectively. CBCA=cannabichromenic acid, CBTA=cannabicitranic acid, CBDA=cannabidiolic acid, THICA=tetrahydroisocannabinolic acid, THCA=tetrahydrocannabinolic acid, and CBLA=cannabicyclolic acid.

FIG. 2A shows a representative total ion chromatogram of 18 reaction sets of cannabinoid synthase orthologues. Each reaction set took 1.7 min to analyze.

FIG. 2B shows a representative extracted ion chromatogram (“EIC”) of the 18 reaction sets of cannabinoid synthase orthologues obtained at mass to charge ratio “(m/z”)=359.5 showing the presence of CBGA that was added to 9 of the 18 reaction sets, i.e., sets 1-3, 7-9, 13-15.

FIG. 2C shows a representative EIC of the 18 reaction sets that exhibited the production of a cannabinoid having at m/z=357.5.

FIG. 3A shows a total-ion chromatograph of a group of 18 cannabinoid synthase orthologues. Each reaction set took 1.7 min.

FIG. 3B shows a representative EIC of the 18 reaction sets of cannabinoid synthase orthologues obtained at m/z=359.5 showing the presence of CBGA that was added to 9 of the 18 reaction sets, i.e., sets 1-3, 7-9, 13-15.

FIG. 3C shows a representative EIC of the 18 reaction sets that exhibited the production of a cannabinoid having at m/z=357.5.

FIG. 4. shows a representative chromatogram of a cannabinoid synthase orthologue that produced a cannabinoid having m/z=357.2071. Each reaction set took 15.70 min. to analyze. Chromatograms in rows 1, 2, and 4 show the presence of a peak when CBGA was incubated with a positive cannabinoid synthase orthologue, the peak being 65-fold larger than the peak found in the control experiment (row 3) performed in the absence of a cannabinoid synthase orthologue.

FIG. 5 shows a representative chromatogram of a cannabinoid synthase orthologue that produced a cannabinoid having m/z=373.2020. Each reaction set took 15.70 min. to analyze. Chromatograms in rows 2-4 show the presence of a peak when CBGA was incubated with a positive cannabinoid synthase orthologue, the peak being 120-fold larger than the peak found in the control experiment (row 1) performed in the absence of a cannabinoid synthase orthologue.

FIG. 6 shows a representative chromatogram of a cannabinoid synthase orthologue that produced a cannabinoid having m/z=329.2122. Each reaction set took 15.70 min. to analyze. Chromatograms in rows 1, 2, and 4 show the presence of a peak when CBGA was incubated with a positive cannabinoid synthase orthologue, the peak being 300-fold larger than the peak found in the control experiment (row 3) performed in the absence of a cannabinoid synthase orthologue.

DETAILED DESCRIPTION

Disclosed are enzymes that catalyze the biosynthesis of cannabinoids from CBGA. These enzymes, not previously known as cannabinoid synthases, are from organisms other than Cannabis sativa. The enzymes can be recombinantly expressed in Saccharomyces cerevisiae and Pichia pastoris in an active form.

The method summarized above for producing a cannabinoid requires contacting CBGA with a cannabinoid synthase orthologue not from Cannabis sativa. The source of the cannabinoid synthase orthologue can be, but is not limited to, Citrus sinensis, Brassica napus, Nicotiana attenuate, Gossypium hirsutum, Oryza sativa subsp. indica, Oryza sativa subsp. japonica, Arabidopsis lyrata subsp. lyrata, Paenibacillus sp. Aloe-11, Streptomyces ipomoeae 91-03, Brassica rapa subsp. pekinensis, Prunus persica, Bacillus subtilis 168, Arabidopsis thaliana, Papaver somniferum, and Phytophthora parasitica P1569.

The cannabinoid synthase orthologue can be, but is not limited to, those shown in Tables 1 and 2 below. Exemplary cannabinoid synthase orthologues can have the amino acid sequence of SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127, or a sequence having 70% or greater (e.g., 70%, 75%, 80%, 85%, 90%, 95%, and 99%) identity to SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127.

The method set forth above can produce cannabinoids having a formula weight of 358.5 g/mol, 374.5 g/mol, or 330.5 g/mol. In a particular method, cannabinoids having a formula weight of 358.5 g/mol, 374.5 g/mol, and 330.5 g/mol are each produced.

Another method produces cannabielsoic acid and cannabielsoin. An example of this method produces cannabinoids that include both cannabielsoic acid and cannabielsoin but the products are free of any cannabinoid having a formula weight of 358.5 g/mol. In this exemplary method, the cannabinoid synthase orthologue includes the amino acid sequence of SEQ ID NOs: 67, 77, 97, or 127 or a sequence having 70% or greater identity to SEQ ID NOs: 67, 77, 97, or 127.

In the methods described above, the cannabinoid synthase orthologue can be a recombinant enzyme. The recombinant enzyme can be produced in, e.g., Saccharomyces cerevisiae, Yarrowia lipolytica, Kluyveromyces marxianus, and Pichia pastoris. A specific method features a recombinant enzyme produced in Saccharomyces cerevisiae or Pichia pastoris.

Also mentioned above is a recombinant cell of Saccharomyces cerevisiae or Pichia pastoris contains in its genome a nucleic acid encoding a cannabinoid synthase orthologue. The orthologue is from an organism other than Cannabis sativa. Exemplary sources of the cannabinoid synthase orthologue are listed above and shown in Tables 1 and 2 below.

The recombinant cell can contain a nucleic acid that encodes a cannabinoid synthase orthologue that includes an amino acid sequence selected from the group consisting of SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127, or a sequence having 70% or greater (e.g., 70%, 75%, 80%, 85%, 90%, 95%, and 99%) identity to SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127.

Without further elaboration, it is believed that one skilled in the art can, based on the disclosure herein, utilize the present disclosure to its fullest extent. The following specific examples are, therefore, to be construed as merely descriptive, and not limitative of the remainder of the disclosure in any way whatsoever. All publications cited herein are incorporated by reference in their entirety.

EXAMPLES

Example 1: Identification and Preparation of Potential Cannabinoid Synthases

Based on its sequence, THCA synthase can be classified as a berberine-bridge FAD-dependent enzyme. Through a search of available sequence databases, 232 related genes were identified that are annotated in the UniProt database as berberine-bridge FAD dependent enzymes. In other words, these 232 genes were potential cannabinoid synthase orthologues.

Each gene sequence was codon-optimized for S. cerevisiae protein expression, synthesized, and cloned into pYES2-CT vector (Thermo Fisher). The vectors were transformed separately into S. cerevisiae BY4741 cells using chemical treatment and grown on SC-URA-glucose selection plates for two days at 30° C. Three single colonies from each plate were picked and replicated onto SC-URA-glucose selection plates and incubated for two days at 30° C. The replicated colonies were grown in 10 mL SC-URA-glucose media for 16 h at 30° C. The cells were then harvested and resuspended in 5 mL SC-URA-galactose media and grown for protein expression for 16 h at 30° C. After 16 h, the cells were harvested again and stored at −20° C. Cells not carrying any cannabinoid synthase orthologue were also prepared as above to serve as a negative control.

The cells were resuspended in 400 μL of 100 mM citrate buffer, pH 5.5 with 1 mM MgCl₂ and 5 units of lyticase. The cells were incubated at 37° C. with shaking for 1 h. One gram of glass beads was added to the suspension and the cells were cracked open using the MP Biomedical FastPrep 24 Tissue Homogenizer. Cell debris was removed by centrifugation for 30 min. at 14,800 rpm at 4° C.

Example 2: Enzymatic Assay

The potential cannabinoid synthase orthologues were tested for enzymatic activity as follows. In a reaction volume of 55 μL, 2.5 μL of 1 mg/mL CBGA, 2.5 μL of 20 mM FAD, and 50 μL of yeast cell supernatants prepared as above were combined and incubated under ambient conditions. A corresponding control reaction lacking CBGA was also carried out. After 24 h, the reactions were extracted three times with ethyl acetate. Samples of the extracted material were dried under vacuum and redissolved in acetonitrile for mass analysis using negative ion mode. EIC for m/z=357.5 and m/z=373.5 were generated for each sample to determine if the biosynthesis of a cannabinoid was catalyzed by the orthologues. The potential reaction products are shown in FIG. 1.

For each potential cannabinoid synthase orthologue, three single yeast colonies were picked and grown as mentioned above. The cell supernatant prepared from each colony was split into six portions. Three portions were incubated with CBGA and three portions were not incubated with CBGA as the negative control reaction. In total, for each potential orthologue, nine reactions were performed in the presence of CBGA and nine reactions were not incubated with CBGA.

A sample incubated with CBGA was considered to be positive for cannabinoid synthesis if the extracted material had a chromatographic peak area in EIC having an abundance of at least 800,000 at m/z=357.5 and/or m/z=373.5. A potential cannabinoid synthase orthologue was considered to be positive if seven out of the nine total reactions with CBGA were positive using the above criteria. The results are shown in Table 1 below, as well as in FIGS. 2A-2C and FIGS. 3A-3C.

FIGS. 2A-2C and 3A-3C are representative chromatograms of a Rapid-Fire/Triple Quad mass analysis. FIG. 2C shows a representative chromatogram showing the presence of a peak at m/z 357.5. FIG. 3C shows a representative chromatogram comparing the presence of a peak at m/z 373.5.

TABLE 1
Activity of cannabinoid synthase orthologues
expressed in S. cerevisiae
UniProt ID		m/z =	m/z =
(SEQ ID NO)	Organism	357.5	373.5
A0A067ESH1	Citrus sinensis	Yes	No
A0A078IY96	Brassica napus	Yes	Yes
A0A1J6KPK0	Nicotiana attenuata	Yes	No
(23)
A0A1U8INJ7	Gossypium hirsutum	Yes	No
A2YDX4	Oryza sativa subsp. indica	Yes	No
A2YRE8	Oryza sativa subsp. indica (Rice)	No	Yes
A3A4W8	Oryza sativa subsp. japonica	Yes	No
A3CBG3	Oryza sativa subsp. japonica	Yes	No
D7MMG9	Arabidopsis lyrata subsp. lyrata	Yes	No
(7)
H6CS09	Paenibacillus sp. Aloe-11	Yes	No
LIKS92	Streptomyces ipomoeae 91-03	Yes	No
LIKUA4	Streptomyces ipomoeae 91-03	Yes	No
M4DIE5	Brassica rapa subsp. pekinensis	Yes	Yes
(16)
M5WQ23	Prunus persica	Yes	Yes
M5X864	Prunus persica	Yes	Yes
(31)
O06997	Bacillus subtilis (strain 168)	Yes	No
O64743	Arabidopsis thaliana	No	Yes
O64745	Arabidopsis thaliana	No	Yes
(37)
P93479	Papaver somniferum	Yes	Yes
(47)
Q93ZA3	Arabidopsis thaliana	No	Yes
Q9FKU8	Arabidopsis thaliana	Yes	No
Q9FKU9	Arabidopsis thaliana	Yes	No
Q9FKV2	Arabidopsis thaliana	Yes	No
Q9FZC5	Arabidopsis thaliana	Yes	No
Q9FZC7	Arabidopsis thaliana	No	Yes
Q9SA86	Arabidopsis thaliana	No	Yes
Q9SA89	Arabidopsis thaliana	No	Yes
Q9SVG3	Arabidopsis thaliana	No	Yes
Q9SVG4	Arabidopsis thaliana	No	Yes
Q9SVG7	Arabidopsis thaliana	No	Yes
V9EEP8	Phytophthora parasitica P1569	No	Yes

Out of the 72 cannabinoid synthase orthologues tested, 20 showed the production of a cannabinoid with a molecular formula of C₂₂H₃₀O₄(MW=358.5; m/z 357.5) and 16 orthologues showed the production of a cannabinoid with a molecular formula of C₂₂H₃₀O₄(MW=374.5; m/z 373.5). Five orthologues showed the production of both types of cannabinoids. See Table 1 above.

Example 3: Cannabinoid Synthase Orthologue Expression in Pichia pastoris

Genes encoding orthologues that showed cannabinoid synthase activity using CBGA as substrate were cloned into a P. pastoris expression system for larger scale protein expression. The expression of THCA synthase in P. pastoris was previously demonstrated. See, e.g., Zirpel et al., Biotechnology Lett. 2015, 37(9):1869-1875 and Lange et al., J. Biotechnol. 2015, 211:68-76.

The genes were cloned into the pPICZA plasmid (Invitrogen) and subsequently integrated into the P. pastoris genome using standard techniques. The resulting P. pastoris integrants were inoculated from agar plates and incubated in 20 mL buffered complex glycerol medium in baffled flasks at 30° C. for 48 h with shaking at 190 rpm. Cells were harvested by centrifugation and resuspended in 200 mL buffered methanol complex medium containing 0.5% w/v casamino acids and 0.01% w/v riboflavin. The expression of orthologue proteins was induced by adding 1% methanol every 24 h for a total of 120 hr.

Cells were harvested by centrifugation and resuspended in Buffer A (100 mM Tris, pH 8.0 and 150 mM NaCl). The cells were lysed using an M110P Microfluidizer® (Microfluidics International Corp.). Cell debris was removed by centrifugation and the cell lysates were loaded onto a 5 mL StrepTrap™ HP column (Cytiva Life Sciences) with a flow rate of 1 mL/min. The column was washed with 25 mL Buffer A, i.e., 5 column volumes (“CV”), and eluted with 6 CV Buffer B (100 mM Tris, pH 8.0, 150 mM NaCl, and 2.5 mM desthiobiotin). Fractions containing protein, identified by an increase in absorbance at 280 nm, were pooled, concentrated, and frozen at −80° C.

In a reaction volume of 50 μL, the cannabinoid synthase purified from was incubated with 150 μM CBGA and 0.2 mM FAD in 50 mM citrate, pH 8.0. The reaction was incubated for 24-48 h at 30° C., followed by the addition of 160 μL of acetonitrile to stop the reaction and precipitate the protein. The mixture (120 μL) was injected into an Agilent InfinityLab Poroshell 120 EC-C18 column for mass analysis using the Agilent 1290 Infinity HPLC coupled with Agilent 6550 iFunnel Q-TOF high resolution mass spectrometer in the negative ion mode. EICs for m/z=357.2071, m/z=373.2020, and m/z=329.2122 were generated for each sample to determine if the biosynthesis of a potential cannabinoid was catalyzed by the orthologue.

The results are shown in FIGS. 4-6 and Table 2 below.

TABLE 2
Activity of cannabinoid synthase orthologues expressed in P. pastoris
UniProt ID		m/z =	m/z =	m/z =
(SEQ ID NO)	Organism	357.2071	373.2020	329.2122
D7MMG9	Arabidopsis lyrata subsp.	Yes	No	No
(7)	lyrata
M4DIE5	Brassica rapa subsp.	Yes	Yes	Yes
(16)	pekinensis
A0A1J6KPK0	Nicotiana attenuata	Yes	Yes	Yes
(23)
M5X864	Prunus persica	Yes	No	No
(31)
O64745	Arabidopsis thaliana	Yes	No	No
(37)
P93479	Papaver somniferum	Yes	Yes	Yes
(47)
A0A1U8G0D2	Capsicum annuum	Yes	Yes	Yes
(57)
A0A1S3XA06	Nicotiana tabacum	No	Yes	Yes
(67)
A0A1S3BDA8	Cucumis melo	No	Yes	Yes
(77)
A0A1U8FGM5	Capsicum annuum	Yes	Yes	Yes
(87)
A0A1U8MHW2	Gossypium hirsutum	No	Yes	Yes
(97)	(Gossypium mexicanum)
A0A1J3CT99	Noccaea caerulescens	Yes	Yes	Yes
(107)	(Thlaspi caerulescens)
A0A1J3J6A2	Noccaea caerulescens	Yes	Yes	Yes
(117)	(Thlaspi caerulescens)
A0A1S3BE31	Cucumis melo	No	Yes	Yes
(127)

Out of the 232 potential CBS orthologs screened, seven orthologs showed the production of two types of cannabinoids, (i) the “cannabidiolic acid group” type having a molecular formula of C₂₂H₃₀O₄(FW=358.5; m/z=357.2071, see FIG. 4) and (ii) cannabielsoic acid, with a molecular formula of C₂₂H₃₀O₄(FW=374.5; m/z=373.2020, see FIG. 5). The decarboxylated product of cannabielsoic acid, namely, cannabielsoin, having a molecular formula of C₂₁H₃₀O₂(FW=330.5; m/z=329.2122, see FIG. 6) was also observed. Three orthologues produced only cannabinoids of the cannabidiolic acid group. Four orthologues produced only cannabielsoic acid and cannabielsoin.

OTHER EMBODIMENTS

All of the features disclosed in this specification may be combined in any combination. Each feature disclosed in this specification may be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is only an example of a generic series of equivalent or similar features.

From the above description, one skilled in the art can easily ascertain the essential characteristics of the present invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. Thus, other embodiments are also within the scope of the following claims.

Claims

1. A method for producing one or more cannabinoids, the method comprising contacting cannabigerolic acid (CBGA) with a cannabinoid synthase orthologue, wherein the orthologue is from an organism other than Cannabis sativa.

2. The method of claim 1, wherein the cannabinoid synthase orthologue is from Citrus sinensis, Brassica napus, Nicotiana attenuata, Gossypium hirsutum, Oryza sativa subsp. indica, Oryza sativa subsp. japonica, Arabidopsis lyrata subsp. lyrata, 10 Paenibacillus sp. Aloe-11, Streptomyces ipomoeae 91-03, Brassica rapa subsp. pekinensis, Prunus persica, Bacillus subtilis 168, Arabidopsis thaliana, Papaver somniferum or Phytophthora parasitica P1569.

3. The method of claim 2, wherein the cannabinoid synthase orthologue is selected from those shown in Tables 1 and 2.

4. The method of claim 3, wherein the cannabinoid synthase orthologue includes an amino acid sequence selected from the group consisting of SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127, or a sequence having 70% or greater identity to SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127.

5. The method of claim 1, wherein the cannabinoids produced have a formula weight of 358.5 g/mol, 374.5 g/mol, or 330.5 g/mol.

6. The method of claim 5, wherein the cannabinoids produced include cannabielsoic acid and cannabielsoin.

7. The method of claim 6, wherein the cannabinoids produced are free of any cannabinoid having a formula weight of 358.5 g/mol and the cannabinoid synthase orthologue includes the amino acid sequence of SEQ ID NOs: 67, 77, 97, or 127 or a sequence having 70% or greater identity to SEQ ID NOs: 67, 77, 97, or 127.

8. The method of claim 1, wherein the cannabinoid synthase orthologue is a recombinant enzyme produced in Saccharomyces cerevisiae, Yarrowia lipolytica, Kluyveromyces marxianus, or Pichia pastoris.

9. The method of claim 8, wherein the cannabinoid synthase orthologue is selected from those shown in Tables 1 and 2.

10. The method of claim 9, wherein the cannabinoid synthase orthologue includes an amino acid sequence selected from the group consisting of SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127, or a sequence having 70% or greater identity to SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127.

11. A recombinant cell of Saccharomyces cerevisiae or Pichia pastoris, comprising in its genome a nucleic acid encoding a cannabinoid synthase orthologue, wherein the cannabinoid synthase orthologue is from Citrus sinensis, Brassica napus, Nicotiana attenuata, Gossypium hirsutum, Oryza sativa subsp. indica, Oryza sativa subsp. japonica, Arabidopsis lyrata subsp. lyrata, Paenibacillus sp. Aloe-11, Streptomyces ipomoeae 91-03, Brassica rapa subsp. pekinensis, Prunus persica, Bacillus subtilis 168, Arabidopsis thaliana, Papaver somniferum or Phytophthora parasitica P1569, and the cannabinoid synthase orthologue is expressed in the recombinant cell in an active form.

12. The recombinant cell of claim 11, wherein the nucleic acid encodes a cannabinoid synthase orthologue selected from those shown in Tables 1 and 2.

13. The recombinant cell of claim 12, wherein the nucleic acid encodes a cannabinoid synthase orthologue that includes an amino acid sequence selected from the group consisting of SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127, or a sequence having 70% or greater identity to SEQ ID NOs: 7, 16, 23, 31, 37, 47, 57, 67, 77, 87, 97, 107, 117, and 127.

14. The recombinant cell of claim 13, wherein the nucleic acid encodes a cannabinoid synthase orthologue that includes the amino acid sequence of SEQ ID NOs: 67, 77, 97, or 127 or a sequence having 70% or greater identity to SEQ ID NOs: 67, 77, 97, or 127.